Header Logo
Last Name

Dr Socrates Herrera Valencia

Title[no position]
Institution[no institution name]
Address[no address]
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Lennon SE, Miranda A, Henao J, Vallejo AF, Perez J, Alvarez A, Arévalo-Herrera M, Herrera S. Malaria elimination challenges in Mesoamerica: evidence of submicroscopic malaria reservoirs in Guatemala. Malar J. 2016 08 30; 15(1):441. PMID: 27577992; PMCID: PMC5006524.
    2. Valencia SH, Ocampo ID, Arce-Plata MI, Recht J, Arévalo-Herrera M. Erratum to: Glucose-6-phosphate dehydrogenase deficiency prevalence and genetic variants in malaria endemic areas of Colombia. Malar J. 2016 Jul 07; 15(1):348. PMID: 27387753.
      View in: PubMed
    3. Valencia SH, Ocampo ID, Arce-Plata MI, Recht J, Arévalo-Herrera M. Glucose-6-phosphate dehydrogenase deficiency prevalence and genetic variants in malaria endemic areas of Colombia. Malar J. 2016 05 26; 15(1):291. PMID: 27225440; PMCID: PMC4880879.
    4. Vallejo AF, Martinez NL, Tobon A, Alger J, Lacerda MV, Kajava AV, Arévalo-Herrera M, Herrera S. Global genetic diversity of the Plasmodium vivax transmission-blocking vaccine candidate Pvs48/45. Malar J. 2016 Apr 12; 15:202. PMID: 27067024; PMCID: PMC4828788.
    5. Alimi TO, Fuller DO, Herrera SV, Arevalo-Herrera M, Quinones ML, Stoler JB, Beier JC. A multi-criteria decision analysis approach to assessing malaria risk in northern South America. BMC Public Health. 2016 Mar 03; 16:221. PMID: 26940004; PMCID: PMC4778356.
    6. Vásquez-Jiménez JM, Arévalo-Herrera M, Henao-Giraldo J, Molina-Gómez K, Arce-Plata M, Vallejo AF, Herrera S. Consistent prevalence of asymptomatic infections in malaria endemic populations in Colombia over time. Malar J. 2016 Feb 06; 15:70. PMID: 26852321; PMCID: PMC4744459.
    7. Lopez-Perez M, Pacheco MA, Buriticá L, Escalante AA, Herrera S, Arévalo-Herrera M. Malaria in pregnancy: a passive surveillance study of pregnant women in low transmission areas of Colombia, Latin America. Malar J. 2016 Feb 05; 15:66. PMID: 26850108; PMCID: PMC4743125.
    8. Vallejo AF, García J, Amado-Garavito AB, Arévalo-Herrera M, Herrera S. Plasmodium vivax gametocyte infectivity in sub-microscopic infections. Malar J. 2016 Jan 28; 15:48. PMID: 26822406; PMCID: PMC4730736.
    9. Alimi TO, Fuller DO, Quinones ML, Xue RD, Herrera SV, Arevalo-Herrera M, Ulrich JN, Qualls WA, Beier JC. Prospects and recommendations for risk mapping to improve strategies for effective malaria vector control interventions in Latin America. Malar J. 2015 Dec 23; 14:519. PMID: 26694047; PMCID: PMC4689006.
    10. Conde M, Pareja PX, Orjuela LI, Ahumada ML, Durán S, Jara JA, Cañon BA, Pérez P, Beier JC, Herrera S, Quiñones ML. Larval habitat characteristics of the main malaria vectors in the most endemic regions of Colombia: potential implications for larval control. Malar J. 2015 Dec 01; 14:476. PMID: 26620401; PMCID: PMC4666185.
    11. Padilla JC, Chaparro PE, Molina K, Arevalo-Herrera M, Herrera S. Is there malaria transmission in urban settings in Colombia? Malar J. 2015 Nov 14; 14:453. PMID: 26573620; PMCID: PMC4647453.
    12. Alimi TO, Fuller DO, Qualls WA, Herrera SV, Arevalo-Herrera M, Quinones ML, Lacerda MV, Beier JC. Predicting potential ranges of primary malaria vectors and malaria in northern South America based on projected changes in climate, land cover and human population. Parasit Vectors. 2015 Aug 20; 8:431. PMID: 26289677; PMCID: PMC4546039.
    13. Orjuela LI, Ahumada ML, Avila I, Herrera S, Beier JC, Quiñones ML. Human biting activity, spatial-temporal distribution and malaria vector role of Anopheles calderoni in the southwest of Colombia. Malar J. 2015 Jun 24; 14:256. PMID: 26104785; PMCID: PMC4477298.
    14. Vallejo AF, Chaparro PE, Benavides Y, Álvarez Á, Quintero JP, Padilla J, Arévalo-Herrera M, Herrera S. High prevalence of sub-microscopic infections in Colombia. Malar J. 2015 May 15; 14:201. PMID: 25971594; PMCID: PMC4438632.
    15. Rosas-Aguirre A, Ponce OJ, Carrasco-Escobar G, Speybroeck N, Contreras-Mancilla J, Gamboa D, Pozo E, Herrera S, Llanos-Cuentas A. Plasmodium vivax malaria at households: spatial clustering and risk factors in a low endemicity urban area of the northwestern Peruvian coast. Malar J. 2015 Apr 24; 14:176. PMID: 25903826; PMCID: PMC4416302.
    16. Arévalo-Herrera M, Lopez-Perez M, Medina L, Moreno A, Gutierrez JB, Herrera S. Clinical profile of Plasmodium falciparum and Plasmodium vivax infections in low and unstable malaria transmission settings of Colombia. Malar J. 2015 Apr 11; 14:154. PMID: 25889074; PMCID: PMC4397685.
    17. Forero DA, Chaparro PE, Vallejo AF, Benavides Y, Gutiérrez JB, Arévalo-Herrera M, Herrera S. Knowledge, attitudes and practices of malaria in Colombia. Malar J. 2014 May 01; 13:165. PMID: 24885909; PMCID: PMC4113137.
    18. Céspedes N, Jiménez E, Lopez-Perez M, Rubiano K, Felger I, Alonso P, Arévalo-Herrera M, Corradin G, Herrera S. Antigenicity and immunogenicity of a novel Plasmodium vivax circumsporozoite derived synthetic vaccine construct. Vaccine. 2014 May 30; 32(26):3179-86. PMID: 24731811.
      View in: PubMed
    19. Herrera S, Vallejo AF, Quintero JP, Arévalo-Herrera M, Cancino M, Ferro S. Field evaluation of an automated RDT reader and data management device for Plasmodium falciparum/Plasmodium vivax malaria in endemic areas of Colombia. Malar J. 2014 Mar 10; 13:87. PMID: 24612585; PMCID: PMC3995821.
    20. Valencia SH, Rodríguez DC, Acero DL, Ocampo V, Arévalo-Herrera M. Platform for Plasmodium vivax vaccine discovery and development. Mem Inst Oswaldo Cruz. 2011 Aug; 106 Suppl 1:179-92. PMID: 21881773; PMCID: PMC4832982.
    21. Herrera S, Quiñones ML, Quintero JP, Corredor V, Fuller DO, Mateus JC, Calzada JE, Gutierrez JB, Llanos A, Soto E, Menendez C, Wu Y, Alonso P, Carrasquilla G, Galinski M, Beier JC, Arévalo-Herrera M. Prospects for malaria elimination in non-Amazonian regions of Latin America. Acta Trop. 2012 Mar; 121(3):315-23. PMID: 21781953; PMCID: PMC3224666.
    22. Arévalo-Herrera M, Vera O, Castellanos A, Céspedes N, Soto L, Corradin G, Herrera S. Preclinical vaccine study of Plasmodium vivax circumsporozoite protein derived-synthetic polypeptides formulated in montanide ISA 720 and montanide ISA 51 adjuvants. Am J Trop Med Hyg. 2011 Feb; 84(2 Suppl):21-7. PMID: 21292874; PMCID: PMC3032486.
    23. Herrera S, Solarte Y, Jordán-Villegas A, Echavarría JF, Rocha L, Palacios R, Ramírez O, Vélez JD, Epstein JE, Richie TL, Arévalo-Herrera M. Consistent safety and infectivity in sporozoite challenge model of Plasmodium vivax in malaria-naive human volunteers. Am J Trop Med Hyg. 2011 Feb; 84(2 Suppl):4-11. PMID: 21292872; PMCID: PMC3032484.
    24. Herrera S, Fernández OL, Vera O, Cárdenas W, Ramírez O, Palacios R, Chen-Mok M, Corradin G, Arévalo-Herrera M. Phase I safety and immunogenicity trial of Plasmodium vivax CS derived long synthetic peptides adjuvanted with montanide ISA 720 or montanide ISA 51. Am J Trop Med Hyg. 2011 Feb; 84(2 Suppl):12-20. PMID: 21292873; PMCID: PMC3032485.
    25. Herrera S, Fernández O, Manzano MR, Murrain B, Vergara J, Blanco P, Palacios R, Vélez JD, Epstein JE, Chen-Mok M, Reed ZH, Arévalo-Herrera M. Successful sporozoite challenge model in human volunteers with Plasmodium vivax strain derived from human donors. Am J Trop Med Hyg. 2009 Nov; 81(5):740-6. PMID: 19861603; PMCID: PMC2826834.
    26. Herrera S, Corradin G, Arévalo-Herrera M. An update on the search for a Plasmodium vivax vaccine. Trends Parasitol. 2007 Mar; 23(3):122-8. PMID: 17258937.
      View in: PubMed
    27. Herrera S, Gómez A, Vera O, Vergara J, Valderrama-Aguirre A, Maestre A, Méndez F, Wang R, Chitnis CE, Yazdani SS, Arévalo-Herrera M. Antibody response to Plasmodium vivax antigens in Fy-negative individuals from the Colombian Pacific coast. Am J Trop Med Hyg. 2005 Nov; 73(5 Suppl):44-9. PMID: 16291766.
      View in: PubMed
    28. Herrera S, Bonelo A, Perlaza BL, Fernández OL, Victoria L, Lenis AM, Soto L, Hurtado H, Acuña LM, Vélez JD, Palacios R, Chen-Mok M, Corradin G, Arévalo-Herrera M. Safety and elicitation of humoral and cellular responses in colombian malaria-naive volunteers by a Plasmodium vivax circumsporozoite protein-derived synthetic vaccine. Am J Trop Med Hyg. 2005 Nov; 73(5 Suppl):3-9. PMID: 16291760.
      View in: PubMed
    29. Herrera S, Bonelo A, Perlaza BL, Valencia AZ, Cifuentes C, Hurtado S, Quintero G, López JA, Corradin G, Arévalo-Herrera M. Use of long synthetic peptides to study the antigenicity and immunogenicity of the Plasmodium vivax circumsporozoite protein. Int J Parasitol. 2004 Dec; 34(13-14):1535-46. PMID: 15582530.
      View in: PubMed
    30. Herrera S, Perlaza BL, Bonelo A, Arévalo-Herrera M. Aotus monkeys: their great value for anti-malaria vaccines and drug testing. Int J Parasitol. 2002 Dec 04; 32(13):1625-35. PMID: 12435447.
      View in: PubMed
    Herrera Valencia's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    Co-Authors Expand Description
    Similar People Expand Description
    Same Department Expand Description